Patrick Weston
Cardiovascular Disease · Bradenton, FLNPI 1306813423
Payments from drug & device makers
Across 721 payments — averaging $1701.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$303K
- Boehringer Ingelheim International GmbH$194K
- Pfizer$143K
- AstraZeneca$140K
- Alnylam Pharmaceuticals Inc.$91K
- Eli Lilly$77K
- plus $278K from 20 others
Across 32 payments — averaging $1825.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$24K
- Vifor (international) Ltd.$20K
- First Wave Biopharma, Inc.$14K
- GSK$916
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 136 | $303,474 |
| Boehringer Ingelheim International GmbH | 118 | $193,634 |
| Pfizer | 36 | $143,065 |
| AstraZeneca | 7 | $140,276 |
| Alnylam Pharmaceuticals Inc. | 276 | $90,516 |
| Eli Lilly | 8 | $77,152 |
| Bausch Health US, LLC | 48 | $73,827 |
| Regeneron | 16 | $44,759 |
| Lexicon Pharmaceuticals, Inc. | 14 | $33,963 |
| Merck | 14 | $30,800 |
| Abbott | 8 | $25,740 |
| Sagent Pharmaceuticals | 7 | $23,882 |
| Partner Therapeutics, Inc. | 5 | $18,195 |
| Gilead | 2 | $10,089 |
| Amgen | 4 | $9,652 |
| Janssen Research & Development, LLC | 4 | $3,072 |
| Vifor (international) Ltd. | 5 | $2,800 |
| Echosens North America, Inc. | 2 | $1,200 |
| Biosense Webster, Inc. | 1 | $99 |
| United Therapeutics Corporation | 1 | $77 |
| Amarin Pharma, Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $26 |
| Medtronic | 1 | $20 |
| Boston Scientific | 1 | $13 |
| Penumbra, Inc. | 1 | $12 |
How this compares
$1,226,426 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Other cardiovascular disease in Bradenton
- Eulogio SanchezBradenton$1.8M
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.